Bioprocessing Of Recombinant CHO-K1, CHO-DG44, And CHO-S: CHO Expression Hosts Favor Either MAb Production Or Biomass Synthesis.
David Reinhart, Lukas Damjanovic, Christian Kaisermayer, Wolfgang Sommeregger, Andreas Gili, Bernhard Gasselhuber, Andreas Castan, Patrick Mayrhofer, Clemens Grünwald-Gruber, Renate Kunert
Published 2019 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Chinese hamster ovary (CHO) cells comprise a variety of lineages including CHO-DXB11, CHO-K1, CHO-DG44, and CHO-S. Despite all CHO cell lines sharing a common ancestor, extensive mutagenesis, and clonal selection has resulted in substantial genetic heterogeneity among them. Data from sequencing show that different genes are missing in individual CHO cell lines and each cell line harbors a unique set of mutations with relevance to the bioprocess. However, not much literature is available about the influence of genetic differences of CHO on the performance of bioprocess operations. In this study, the host cell-specific differences among three widely used CHO cell lines (CHO-K1, CHO-S, and CHO-DG44) and recombinantly expressed the same monoclonal antibody (mAb) in an isogenic format by using bacterial artificial chromosomes (BACs) as transfer vector in all cell lines is examined. Cell-specific growth and product formation are studied in batch, fed-batch, and semi-continuous perfusion cultures. Further, two different cell culture media are used to investigate their effects. The authors find CHO cell line-specific preferences for mAb production or biomass synthesis that are determined by the host cell line. Additionally, quality attributes of the expressed mAb are influenced by the host cell line and media.
This paper references
Primer3Plus, an enhanced web interface to Primer3
Andreas Untergasser (2007)
GENETICS OF SOMATIC MAMMALIAN CELLS : III. LONG-TERM CULTIVATION OF EUPLOID CELLS FROM HUMAN AND ANIMAL SUBJECTS
Theodore T. Puck (1958)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh (2006)
Genetic characterization of CHO production host DG44 and derivative recombinant cell lines.
Madiha Derouazi (2006)
The Genomic Sequence of the Chinese Hamster Ovary (CHO) K1 cell line
Xun Xu (2011)
Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities
Shan Chung (2012)
Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
Liming Liu (2015)
Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression
Andrew G. Buchanan (2013)
Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.
Gail Urlaub (1980)
The chromosomes of CHO, an aneuploid Chinese hamster cell line: G-band, C-band, and autoradiographic analyses
Larry L. Deaven (2004)
Chinese hamster ovary K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11-derived dihydrofolate reductase deficient host cell.
Zhilan Hu (2013)
CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
Rhian K Grainger (2013)
Transcriptome dynamics of transgene amplification in Chinese hamster ovary cells.
Nandita Vishwanathan (2014)
Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Malcolm L. Kennard (2009)
Influence of glycosylation pattern on the molecular properties of monoclonal antibodies
Kai Zheng (2014)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Kenneth J Livak (2001)
A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.
Jennifer D. Könitzer (2015)
The impact of intragenic CpG content on gene expression
Asli Petra Bauer (2010)
Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells
Gail Urlaub (1983)
A broad range of Fab stabilities within a host of therapeutic IgGs.
Ellen E. Garber (2007)
A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies.
Minsoo Kim (2011)
Quality control in the endoplasmic reticulum
Lars Ellgaard (2003)
Heterologous protein production using euchromatin-containing expression vectors in mammalian cells
Katalin Zboray (2015)
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
Marcella Yu (2012)
A clone screening method using mRNA levels to determine specific productivity and product quality for monoclonal antibodies.
Christina J Lee (2009)
Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM).
Thomas Simmen (2010)
Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry.
Guillaume Chevreux (2011)
Modulating IgG effector function by Fc glycan engineering
Tiezheng Li (2017)
Transgene copy number comparison in recombinant mammalian cell lines: critical reflection of quantitative real-time PCR evaluation
Wolfgang Sommeregger (2013)
The absence of effect of gene copy number and mRNA level on the amount of mAb secretion from mammalian cells
Hannes Reisinger (2008)
Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome.
Nathan E. Lewis (2013)
Genomics in mammalian cell culture bioprocessing.
Diane M. Wuest (2012)
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.
Louise C. Laurent (2011)
Recombinant protein therapeutics from CHO Cells - 20 years and counting
Karthik P. Jayapal (2007)
DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines.
Yuansheng Yang (2010)
The role of sialic acid in determining the survival of glycoproteins in the circulation.
A. Gilabert Morell (1971)
In search of expression bottlenecks in recombinant CHO cell lines—a case study
David Reinhart (2014)
Genetic analyses of Per.C6 cell clones producing a therapeutic monoclonal antibody regarding productivity and long-term stability
Lilian Rumi Tsuruta (2016)
Proteomic differences in recombinant CHO cells producing two similar antibody fragments
Wolfgang Sommeregger (2016)
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity
Elisa Närvä (2010)
Benchmarking of commercially available CHO cell culture media for antibody production
David Reinhart (2013)
Exploration of BAC versus plasmid expression vectors in recombinant CHO cells
Alexander Oliver Mader (2012)
Advances in recombinant antibody manufacturing
Renate Kunert (2016)
First CHO genome
F. M. Wurm (2011)
Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity
Y. -C. Shen (2013)
Glycosylation as a strategy to improve antibody-based therapeutics
Royston Jefferis (2009)
Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
Michael J. Gramer (2011)
Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment.
Anne Kantardjieff (2010)
Glycosylation of recombinant antibody therapeutics.
Royston Jefferis (2005)
This paper is referenced by
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
Nagesh K Tripathi (2019)
Germinality does not necessarily define mAb expression and thermal stability
Linda Schwaigerlehner (2019)
Oxidative stress‐alleviating strategies to improve recombinant protein production in CHO cells
Valentine Chevallier (2019)
Strategies to enhance productivity and modify product quality in therapeutic proteins
Devesh Radhakrishnan (2018)
Biotechnology and Bioengineering
Valentine Chevallier (2020)
mRNA Transfection in CHO-cells Reveals Production Bottleneck.
Michael T Coats (2019)
A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer
Jieheng Wu (2019)
Multi-omics profiling of CHO parental hosts reveals cell line-specific variations in bioprocessing traits
Meiyappan Lakshmanan (2019)